Tenet Healthcare Corp: Form 10-Q for the period ended Jun 30, 2019
Filed with the SEC on Aug 5, 2019 and accepted by EDGAR at Aug 5, 2019, 16:26 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Operating income | 3 months2019-04-01 to 2019-06-30 | $388.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2019-01-01 to 2019-06-30 | $759.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-04-01 to 2019-06-30 | $247.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2019-01-01 to 2019-06-30 | $498.0m | us-gaap:InterestExpense |
| Income tax | 3 months2019-04-01 to 2019-06-30 | $30.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2019-01-01 to 2019-06-30 | $47.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-04-01 to 2019-06-30 | $112.0m | us-gaap:ProfitLoss |
| Net income | 6 months2019-01-01 to 2019-06-30 | $177.0m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2019-04-01 to 2019-06-30 | $0.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2019-01-01 to 2019-06-30 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-04-01 to 2019-06-30 | $0.17 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2019-01-01 to 2019-06-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-04-01 to 2019-06-30 | 104,629,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2019-01-01 to 2019-06-30 | 102,993,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2019-01-01 to 2019-06-30 | $294.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2019-01-01 to 2019-06-30 | $336.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2019-06-30 | $249.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-06-30 | $4.70bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-06-30 | $23.21bn | us-gaap:Assets |
| Current liabilities | At period end2019-06-30 | $4.15bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-06-30 | $21.03bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-06-30 | −$108.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000070318-19-000039. Last ingested by Listed: Nov 15, 2026, 02:42 ET. Listed shows no prices and gives no investment advice.